Roswell Biotechnologies
Sandra Schmid is the Chief Scientific Officer at Chan Zuckerberg Biohub since June 2020, where collaboration with leadership and platform leaders focuses on advancing the scientific objectives of interdisciplinary research programs aimed at understanding disease mechanisms. At UT Southwestern Medical Center, Sandra serves as an Adjunct Professor and as a Professor and Chairman of Cell Biology, driving faculty recruitment and fostering collaboration while continuing research on clathrin-mediated endocytosis. Previous roles include serving as Professor and Chairman at The Scripps Research Institute, contributing to faculty recruitment and mentorship in cell biology and conducting significant research on endocytosis. Sandra has held leadership positions in professional organizations, including President of the American Society for Cell Biology, and has an extensive educational background with a Ph.D. in Biochemistry from Stanford University and an MSEL in Executive Leadership from the University of San Diego.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
Roswell Biotechnologies
Roswell Biotechnologies is digitizing biology through molecular electronics to elucidate, diagnose and treat disease. The company has developed the world's first molecular electronics chip, the Roswell ME Chip, by integrating single molecules into standard semiconductor chip technology to deliver a powerful biosensor that converges all omics on one platform.